drugset / Trial / NCT00277355

Pilot Study of Minocycline in Huntington's Disease

NCT00277355

RandomizedParallel-groupDouble-blindTreatment

Summary

This study is being conducted to assess the impact of minocycline on the progression of symptoms of HD. The study will also assess whether it is reasonable to continue with further study of minocycline in HD. We will measure the effect of minocycline on HD by measuring the change in Huntington's disease symptoms.

Timeline

Start
2006-04
Primary completion
2008-10
Completion
2008-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Minocycline Small molecule 100 mg Oral

Indications